Blog
The Arjus Blog
Data-led analysis and commentary on NHS general practice and primary care — built on the same national datasets that power the Arjus dashboards. Written by Dr Yogasakaran Arjuna.
CVD Prevention · National Audit
CVDPREVENT: England, to March 2026
25 August 2026 · Dr Yogasakaran Arjuna
The March 2026 extraction is the first full quarter to show what happens when a fifth of QOF is torn up and re-aimed at cardiovascular prevention: blood pressure control hit a record high, lipid optimisation accelerated, smoking-cessation support fell off a cliff — and seven new indicators set the national baseline for SGLT2 inhibitors.
71.4%
BP controlled, hypertension <80 — record high
+4.7 pts
CVD patients at cholesterol target, year on year
−13.2 pts
Smokers offered cessation support
1 in 3
Eligible patients on an SGLT2 inhibitor — new baseline